Pluristem Therapeutic (PSTI +1%) ticks higher after reporting its PLX cells tested in...


Pluristem Therapeutic (PSTI +1%) ticks higher after reporting its PLX cells tested in preclinical animal models of preeclampsia effectively improved several parameters of the disease. Details of the study will be presented on May 30th at the Society for Gynecological Investigation Summit in Jerusalem.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs